Clinical Trials Directory

Trials / Conditions / Ovarian Clear Cell Carcinoma

Ovarian Clear Cell Carcinoma

19 registered clinical trials studyying Ovarian Clear Cell Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingLiposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovaria
NCT07239622
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
Not Yet RecruitingINVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT07002346
Tongji HospitalPhase 3
RecruitingSafety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
NCT06065462
M.D. Anderson Cancer CenterPhase 1 / Phase 2
RecruitingA Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06279104
Tongji Hospital—
UnknownZimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma
NCT05759312
Fudan UniversityPhase 1 / Phase 2
UnknownAMT-151 in Patients With Selected Advanced Solid Tumours
NCT05498597
Multitude Therapeutics Inc.Phase 1
UnknownA Study of Camrelizumab in Combination With Anlotinib in Subjects Advanced Ovarian Clear Cell Carcinoma
NCT05600998
Peking University Third HospitalN/A
UnknownStudy of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
NCT05415098
Ascentage Pharma Group Inc.Phase 1
Active Not RecruitingPembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
NCT05296512
Elizabeth K. Lee MDPhase 2
RecruitingEfficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherap
NCT05281471
Genelux CorporationPhase 3
Active Not RecruitingA Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Ca
NCT05226507
Nuvectis Pharma, Inc.Phase 1
UnknownAsian Multicenter Prospective Study of ctDNA Sequencing
NCT05099978
National Cancer Center, Japan—
CompletedSintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma
NCT04735861
Tongji HospitalPhase 2
RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776
Novartis PharmaceuticalsPhase 1 / Phase 2
UnknownA Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear C
NCT03405454
National University Hospital, SingaporePhase 2
CompletedA Study of PLX2853 in Advanced Malignancies.
NCT03297424
Opna Bio LLCPhase 1
TerminatedA Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clea
NCT02837991
Celldex TherapeuticsPhase 1
UnknownStudy Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or E
NCT02866370
NHS Greater Glasgow and ClydePhase 2
CompletedA Study of ENMD-2076 in Ovarian Clear Cell Cancers
NCT01914510
University Health Network, TorontoPhase 2